237 related articles for article (PubMed ID: 33976736)
1. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
[TBL] [Abstract][Full Text] [Related]
2. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
Front Oncol; 2020; 10():591254. PubMed ID: 33324563
[TBL] [Abstract][Full Text] [Related]
3. Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
J Cancer; 2021; 12(8):2359-2370. PubMed ID: 33758612
[TBL] [Abstract][Full Text] [Related]
4. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
5. Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma.
Li R; Jiang X; Wang P; Liu X
Front Oncol; 2023; 13():1205713. PubMed ID: 37519809
[TBL] [Abstract][Full Text] [Related]
6. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy
Zhong W; Zhong H; Zhang F; Huang C; Lin Y; Huang J
Front Mol Biosci; 2021; 8():684050. PubMed ID: 34250018
[No Abstract] [Full Text] [Related]
8. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
Yuan B; Li F; Li Y; Chen Y
Cancer Manag Res; 2020; 12():4017-4027. PubMed ID: 33116819
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma.
Lv Z; Qi L; Hu X; Mo M; Jiang H; Li Y
Front Oncol; 2021; 11():633950. PubMed ID: 33816274
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance.
Zheng D; Ning J; Xia Y; Ruan Y; Cheng F
Front Oncol; 2022; 12():1008714. PubMed ID: 36387262
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
12. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
[TBL] [Abstract][Full Text] [Related]
14. The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.
Wang C; Qin X; Guo W; Wang J; Liu L; Fang Z; Yuan H; Fan Y; Xu D
Front Oncol; 2023; 13():1133902. PubMed ID: 37197417
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
Front Genet; 2020; 11():568192. PubMed ID: 33133154
[TBL] [Abstract][Full Text] [Related]
16. Identification of 12 immune-related lncRNAs and molecular subtypes for the clear cell renal cell carcinoma based on RNA sequencing data.
Zhong W; Chen B; Zhong H; Huang C; Lin J; Zhu M; Chen M; Lin Y; Lin Y; Huang J
Sci Rep; 2020 Sep; 10(1):14412. PubMed ID: 32879362
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients.
Li H; Chen L; Ke ZB; Chen SH; Xue XY; Zheng QS; Wei Y; Zeng K; Xu N
Int J Gen Med; 2021; 14():6325-6342. PubMed ID: 34629897
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a seven-gene signature for predicting overall survival in patients with kidney renal clear cell carcinoma via an integrated bioinformatics analysis.
Jiang H; Chen H; Chen N
Anim Cells Syst (Seoul); 2020 May; 24(3):160-170. PubMed ID: 33209196
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
Chang K; Yuan C; Liu X
Front Oncol; 2021; 11():649347. PubMed ID: 33996565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
